Therapy for H. Pylori Infection

Overview

Journal Curr Gastroenterol Rep

Specialty Gastroenterology

Date 2000 Sep 12

PMID 10980996

Authors

A B Thomson

Affiliations

Soon will be listed here.

Abstract

The discovery that peptic ulcers can be caused by gastroduodenal infection with Helicobacter pylori and cured by eradication of this bacterial presence has made a profound impact on ulcer management. This article reviews the principles behind such treatment and the regimens in current use, including proton pump inhibitor triple therapies and ranitidine bismuth citrate triple therapies.

References

Ducons J, Santolaria S, Guirao R, Ferrero M, Montoro M, Gomollon F . Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a prospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer. Aliment Pharmacol Ther. 1999; 13(6):775-80. DOI: 10.1046/j.1365-2036.1999.00549.x. View

Veldhuyzen van Zanten S, Sherman P . Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview. CMAJ. 1994; 150(2):177-85. PMC: 1486230. View

Laine L, Hopkins R, Girardi L . Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials. Am J Gastroenterol. 1998; 93(9):1409-15. DOI: 10.1111/j.1572-0241.1998.452_a.x. View

Huang J, Hunt R . The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole. Aliment Pharmacol Ther. 1999; 13(6):719-29. DOI: 10.1046/j.1365-2036.1999.00530.x. View

Hawkey C, Karrasch J, SZCZEPANSKI L, Walker D, Barkun A, Swannell A . Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med. 1998; 338(11):727-34. DOI: 10.1056/NEJM199803123381105. View

Yeomans N, Tulassay Z, Juhasz L, Racz I, Howard J, Van Rensburg C . A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med. 1998; 338(11):719-26. DOI: 10.1056/NEJM199803123381104. View

Graham D, Adam E, Reddy G, Agarwal J, Agarwal R, Evans Jr D . Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci. 1991; 36(8):1084-8. DOI: 10.1007/BF01297451. View

McColl K, Murray L, El-Omar E, Dickson A, Wirz A, Kelman A . Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med. 1998; 339(26):1869-74. DOI: 10.1056/NEJM199812243392601. View

Zanten S, Bradette M, Farley A, Leddin D, Lind T, Unge P . The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. Aliment Pharmacol Ther. 1999; 13(3):289-95. DOI: 10.1046/j.1365-2036.1999.00471.x. View

10.

Lind T, van Zanten S, Unge P, Spiller R, Bayerdorffer E, OMorain C . Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. Helicobacter. 1996; 1(3):138-44. DOI: 10.1111/j.1523-5378.1996.tb00027.x. View

11.

Armstrong D . Helicobacter pylori infection and dyspepsia. Scand J Gastroenterol Suppl. 1996; 215:38-47. View

12.

Parsonnet J, Harris R, Hack H, Owens D . Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet. 1996; 348(9021):150-4. DOI: 10.1016/s0140-6736(96)01501-2. View

13.

Spadaccini A, De Fanis C, Sciampa G, Russo L, Silla M, Pantaleone U . Triple regimens using lansoprazole or ranitidine bismuth citrate for Helicobacter pylori eradication. Aliment Pharmacol Ther. 1998; 12(10):997-1001. DOI: 10.1046/j.1365-2036.1998.00392.x. View

14.

Hunt R, Thomson A . Canadian Helicobacter pylori consensus conference. Canadian Association of Gastroenterology. Can J Gastroenterol. 1998; 12(1):31-41. DOI: 10.1155/1998/170180. View

15.

Sung J, Leung W, Ling T, Yung M, Chan F, Lee Y . One-week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer. Aliment Pharmacol Ther. 1998; 12(8):725-30. DOI: 10.1046/j.1365-2036.1998.00367.x. View

16.

Graham D, Malaty H, Evans D, Evans Jr D, KLEIN P, Adam E . Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology. 1991; 100(6):1495-501. DOI: 10.1016/0016-5085(91)90644-z. View

17.

Lam S, Talley N . Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol. 1998; 13(1):1-12. DOI: 10.1111/j.1440-1746.1998.tb00537.x. View

18.

Malfertheiner P, Bayerdorffer E, Diete U, Gil J, Lind T, MISIUNA P . The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. Aliment Pharmacol Ther. 1999; 13(6):703-12. DOI: 10.1046/j.1365-2036.1999.00535.x. View

19.

Marshall B, Warren J . Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984; 1(8390):1311-5. DOI: 10.1016/s0140-6736(84)91816-6. View

20.

Veldhuyzen van Zanten S, Sherman P, Hunt R . Helicobacter pylori: new developments and treatments. CMAJ. 1997; 156(11):1565-74. PMC: 1227498. View